Global Antifungal Drug Market will reach USD 14.10 Billion by 2021: Zion Market Research
Sarasota, FL, Dec. 30, 2016 (GLOBE NEWSWIRE) — Zion Research has published a new report titled “Antifungal Drug Market by Drug Type (Echinocandins, Azoles, Ployenes, Allylamines and Others) and by Dosage Form (Powders, Ointments, Drugs and Pastes) for Aspergillosis, Dermatophytosis, Candidiasis and Others – Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021”. According to the report, the global antifungal drug market accounted for around USD 11.30 billion in 2015 and is expected to reach approximately USD 14.10 billion by 2021, growing at a CAGR of around 3.6% between 2015 and 2021.
Fungi are quite different from bacteria in physical characteristics like size, cellular structure, and chemical composition. Fungi are considered as a “higher beings” when it is compared with bacteria, viruses, and another small micro-organism. It may contain one nucleus or multiple nuclei surrounded by a specific cell wall. However, fungi life cycle may vary from simple to complex and it may reproduce by both asexual and sexual reproduction. Because of the distinct feature, fungi are considered to be much more complex than bacteria. Fungi are also able to adjust and reproduce in abnormal environments such as mammalian tissue. In particular, yeasts is a class of fungi which readily adapts to the human environment and organisms such as Candida species are normal inhabitants of the skin, gastrointestinal tract, female genital tract and urine.
Browse through 33 Market Tables and 39 Figures spread over 110 Pages and in-depth TOC on “Global Antifungal Drug Market: By Type, Form, Size, Share, Analysis, Segment and Forecast 2015-2021”.
Request free Sample copy of Antifungal Drug Market Report @ https://www.zionmarketresearch.com/sample/antifungal-drug-market
The antifungal drug market is majorly driven by increasing the prevalence of fungal infection across the globe. Furthermore, increasing awareness is a major key factor which is expected to promote the growth of antifungal drug market. Moreover, torpid lifestyle and the compromised immune system can affect antifungal drug market. However, huge penetration of conventional medication coupled with the traditional approach of treatment is the key restraining factor for the growth of anti-fungal drug market. Nonetheless, ongoing research and development in developing anti fungal drugs are likely to bring growth avenues in the future market.
Based on drug type, the global market of the antifungal drug is segmented into five types: echinocandins, azoles, ployenes, allylamines and others. The echinocandins represent the first new class of antifungal drug which was introduced for more than 15 years. This drug acts by inhibiting the cell wall synthesis of fungi (by inhibiting β-D-glucan). Their potency includes low toxicity, rapid fungicidal activity against most isolates of Candida spp. and predictable constructive kinetics allowing once a day dosing. The first licensed echinocandin product is caspofungin acetate. In terms of revenue, Azole derivatives were the leading drug type segment in antifungal drug market in 2015.
Browse the full “Antifungal Drug Market by Drug Type (Echinocandins, Azoles, Ployenes, Allylamines and Others) and by Dosage Form (Powders, Ointments, Drugs and Pastes) for Aspergillosis, Dermatophytosis, Candidiasis and Others Infection – Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021” report at https://www.zionmarketresearch.com/report/antifungal-drug-market
Based on therapeutic indication, the global market of the antifungal drug is segmented into four types: aspergillosis, dermatophytosis, candidiasis and others. In terms of therapeutic indication, dermatophytosis which is the most common ring worm infections dominates the therapeutic indication market. Dermatophytosis is a common fungal infection of the skin. Infections result in a red, itchy, scaly, circular rash. Hair loss may occur in the affected area of skin especially seen in the child. They are typical of the Trichophyton, Microsporum, or Epidermophyton type. Ringworm infection usually spread by using public showers, contact sports such as wrestling, excessive sweating, contact with animals, obesity, and poor immune function.
Based on the dosage form, the global market of the antifungal drug is bifurcated into four types: powders, ointments, drugs, and pastes. Powder and ointment dosage form dominate the dosage form market in 2015. The growth is attributed due to easy availability of antifungal OTC products in the medical store. It is estimated that the OTC segment of antifungal drugs market is expected to grow at a CAGR of approximately 4.1% within the forecast period.
Inquire more about this report @ https://www.zionmarketresearch.com/inquiry/antifungal-drug-market
North America is expected to witness an average growth estimated due to the precautionary care, awareness and favorable government initiatives in the U.S. However, the demand for the antifungal drug has been increasing in the past few years owing to the rising awareness regarding the severity of the fungal infection. North America market is projected to expand at a CAGR of approximately 0.8% during the forecast period.
Europe was the second largest regional segment of the global antifungal market in 2015 in terms of revenue. This growth is attributed due to high literacy rate, the presence of a number of countries with high human development index, awareness and government initiatives over controlling fungal infection.
Request a customized copy of report @ https://www.zionmarketresearch.com/custom/534
Asia Pacific is expected to be the fastest growing regional segment for the antifungal drug market in 2015 within the forecast period due to the rapid spread of fungal infection in this region. Asia Pacific accounted as a leading market of the global antifungal drug market in 2015 in terms of growth. In addition rising awareness towards personal care in emerging economies of China and India is expected to augment the growth of antifungal drug market in the region. India’s tropical environment is a breeding ground for diverse types of fungi and therefore provides a lot of opportunities to the pharmaceutical operators to keep the drug market flooded with various anti-fungal drugs. According to AIOCD Pharmasofttech AWACS data, the total anti-fungal market in India across different categories is pegged at an approximately USD 161.30 million, growing at around 27%.
The Latin American and the Middle East and Africa region will experience the significant growth during the forecast period. This growth is attributed due to the tropical climate of this region which is proliferation place for varieties of fungi. Latin America is expected to experience significant growth with CAGR of around 8.3% within the forecast period.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global antifungal drug market include Asperqillus, Alternaria, Abbott Laboratories, Pfizer, GlaxoSmithKline, Bayer Healthcare, Novartis, Sanofi-Aventis, Merck & Co., Kramer Laboratories, Enzon Pharmaceuticals, and Gilead.
Purchase a direct copy of report with TOC @ https://www.zionmarketresearch.com/buynow/su/antifungal-drug-market
This report segments the global antifungal drug market as follows:
Global Antifungal Drug Market: Drug Type Analysis
- Echinocandins
- Azoles
- Polyenes
- Allylamines
- Others
Global Antifungal Drug Market: Therapeutic Indication Analysis
- Aspergillosis
- Dermatophytosis
- Candidiasis
- Others
Global Antifungal Drug Market: Dosage Form Analysis
- Powders
- Ointments
- Drugs
- Pastes
Global Antifungal Drug Market: Regional Segment Analysis
- North America
- US
- Europe
- UK
- Germany
- France
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- Middle East And Africa
Related Reports:
- General Anxiety Disorder Market: https://www.zionmarketresearch.com/report/general-anxiety-disorder-market
- Drug Discovery Informatics Market: https://www.zionmarketresearch.com/report/drug-discovery-informatics-market
- Ultrasound Market: https://www.zionmarketresearch.com/report/ultrasound-market
- Active Pharmaceutical Ingredients market: https://www.zionmarketresearch.com/report/active-pharmaceutical-ingredients-market
About Us:
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research
Follow Us Twitter: https://twitter.com/zion_research
Contact Us: Joel John 4283, Express Lane, Suite 634-143, Sarasota, Florida 34249, United States Tel: +49-322 210 92714 USA/Canada Toll-Free No.1-855-465-4651 Email: [email protected] Website: https://www.zionmarketresearch.com/
